{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:32:55Z","timestamp":1791894775532,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012544","name":"China Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["110QR001I5"],"award-info":[{"award-number":["110QR001I5"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2223-E-007-003"],"award-info":[{"award-number":["110-2223-E-007-003"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2622-8-007-015"],"award-info":[{"award-number":["110-2622-8-007-015"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2634-F-007-023"],"award-info":[{"award-number":["110-2634-F-007-023"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-EX110-11014BI"],"award-info":[{"award-number":["NHRI-EX110-11014BI"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU107-TU-08"],"award-info":[{"award-number":["CMU107-TU-08"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jconrel.2021.09.008","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T23:03:09Z","timestamp":1631228589000},"page":"694-704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Polyplex nanomicelle delivery of self-amplifying RNA vaccine"],"prefix":"10.1016","volume":"338","author":[{"given":"Yi-Hao","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chen","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Ming","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-En","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.09.008_bb0005","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2\u2014preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.addr.2021.01.003","article-title":"Advances in gene-based vaccine platforms to address the COVID-19 pandemic","volume":"170","author":"Pushparajah","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba2422","article-title":"Single-dose mRNA therapy via biomaterial-mediated sequestration of overexpressed proteins","volume":"6","author":"Khalil","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0025","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1038\/s41467-020-17409-9","article-title":"Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice","volume":"11","author":"McKay","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0030","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice","volume":"28","author":"Freyn","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0040","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ymthe.2018.12.013","article-title":"Self-amplifying RNA vaccines for Venezuelan equine encephalitis virus induce robust protective immunogenicity in mice","volume":"27","author":"Samsa","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/bs.adgen.2014.10.005","article-title":"Self-amplifying mRNA vaccines","volume":"89","author":"Brito","year":"2015","journal-title":"Adv. Genet."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ymthe.2019.09.009","article-title":"A trans-amplifying RNA vaccine strategy for induction of potent protective immunity","volume":"28","author":"Beissert","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145130","article-title":"Self-amplifying RNA viruses as RNA vaccines","volume":"21","author":"Lundstrom","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc9396","article-title":"An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates","volume":"12","author":"Erasmus","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0065","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0070","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/infdis\/jiu522","article-title":"Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion","volume":"211","author":"Bogers","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0075","doi-asserted-by":"crossref","first-page":"E4133","DOI":"10.1073\/pnas.1600299113","article-title":"Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and toxoplasma gondii challenges with a single dose","volume":"113","author":"Chahal","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0080","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/JVI.01786-15","article-title":"Induction of broad-based immunity and protective efficacy by self-amplifying mRNA vaccines encoding influenza virus hemagglutinin","volume":"90","author":"Brazzoli","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba5068","article-title":"Development of a potent Zika virus vaccine using self-amplifying messenger RNA","volume":"6","author":"Luisi","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0090","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.ymthe.2018.07.010","article-title":"A nanostructured lipid carrier for delivery of a replicating viral RNA provides single, low-dose protection against Zika","volume":"26","author":"Erasmus","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0095","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jconrel.2020.06.027","article-title":"Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: the impact of cationic lipid selection","volume":"325","author":"Lou","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161193","article-title":"Self-amplifying mRNA vaccines expressing multiple conserved influenza antigens confer protection against homologous and heterosubtypic viral challenge","volume":"11","author":"Magini","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jconrel.2019.04.043","article-title":"Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA","volume":"304","author":"Blakney","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0110","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/mt.2014.133","article-title":"A cationic nanoemulsion for the delivery of next-generation RNA vaccines","volume":"22","author":"Brito","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2017.09.018","article-title":"Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure","volume":"266","author":"D\u00e9moulins","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.24","article-title":"Self-replicating replicon-RNA delivery to dendritic cells by chitosan-nanoparticles for translation in vitro and in vivo","volume":"3","author":"McCullough","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.biomaterials.2015.12.031","article-title":"Systemic delivery of messenger RNA for the treatment of pancreatic cancer using polyplex nanomicelles with a cholesterol moiety","volume":"82","author":"Uchida","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0130","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza a virus infection","volume":"30","author":"Petsch","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0135","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jconrel.2016.06.001","article-title":"Messenger RNA-based therapeutics for brain diseases: an animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles","volume":"235","author":"Lin","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0140","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.omtn.2019.02.012","article-title":"Treatment of intervertebral disk disease by the administration of mRNA encoding a cartilage-anabolic transcription factor","volume":"16","author":"Lin","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0145","doi-asserted-by":"crossref","first-page":"12396","DOI":"10.1021\/ja506194z","article-title":"Modulated protonation of side chain aminoethylene repeats in N-substituted polyaspartamides promotes mRNA transfection","volume":"136","author":"Uchida","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biomaterials.2019.01.023","article-title":"Induced packaging of mRNA into polyplex micelles by regulated hybridization with a small number of cholesteryl RNA oligonucleotides directed enhanced in vivo transfection","volume":"197","author":"Yoshinaga","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1297-9716-44-17","article-title":"Immunogenic and protective properties of GP5 and M structural proteins of porcine reproductive and respiratory syndrome virus expressed from replicating but nondisseminating adenovectors","volume":"44","author":"Roques","year":"2013","journal-title":"Vet. Res."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0160","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3389\/fmicb.2017.01635","article-title":"Improved vaccine against PRRSV: current progress and future perspective","volume":"8","author":"Nan","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0165","doi-asserted-by":"crossref","first-page":"10781","DOI":"10.1038\/s41598-019-47239-9","article-title":"Efficacy of type 2 PRRSV vaccine against challenge with the Chinese lineage 1 (NADC30-like) PRRSVs in pigs","volume":"9","author":"Wei","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0170","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1038\/s41598-019-39059-8","article-title":"Emergence of two different recombinant PRRSV strains with low neutralizing antibody susceptibility in China","volume":"9","author":"Han","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.virusres.2010.07.029","article-title":"The structural biology of PRRSV","volume":"154","author":"Dokland","year":"2010","journal-title":"Virus Res."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0180","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.80.8.3994-4004.2006","article-title":"Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies","volume":"80","author":"Ansari","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0185","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.stem.2013.06.001","article-title":"Efficient generation of human iPSCs by a synthetic self-replicative RNA","volume":"13","author":"Yoshioka","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtice.2017.10.020","article-title":"Production and purification of virus-like particles of different enterovirus subtypes as vaccines","volume":"82","author":"Lin","year":"2018","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.01.033","article-title":"Enhanced critical-size calvarial bone healing by ASCs engineered with Cre\/loxP-based hybrid baculovirus","volume":"124","author":"Lo","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0200","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz267","article-title":"CRISPRai for simultaneous gene activation and inhibition to promote stem cell chondrogenesis and calvarial bone regeneration","volume":"47","author":"Truong","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/nano9010067","article-title":"Preparation of messenger RNA nanomicelles via non-cytotoxic PEG-polyamine nanocomplex for intracerebroventicular delivery: a proof-of-concept study in mouse models","volume":"9","author":"Chan","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0210","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3390\/molecules24071303","article-title":"PEG-OligoRNA hybridization of mRNA for developing sterically stable lipid nanoparticles toward in vivo administration","volume":"24","author":"Kurimoto","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0215","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/bit.25625","article-title":"Enhanced enterovirus 71 virus-like particle yield from a new baculovirus design","volume":"112","author":"Lin","year":"2015","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0220","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virusres.2010.09.003","article-title":"Taming PRRSV: revisiting the control strategies and vaccine design","volume":"154","author":"Thanawongnuwech","year":"2010","journal-title":"Virus Res."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12943-021-01311-z","article-title":"mRNA vaccine: a potential therapeutic strategy","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jviromet.2016.03.021","article-title":"Generation of porcine reproductive and respiratory syndrome (PRRS) virus-like-particles (VLPs) with different protein composition","volume":"236","author":"Garc\u00eda Dur\u00e1n","year":"2016","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/v12111245","article-title":"Porcine reproductive and respiratory syndrome virus reverse genetics and the major applications","volume":"12","author":"Chaudhari","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11262-005-5839-y","article-title":"Enhanced immunogenicity of the modified GP5 of porcine reproductive and respiratory syndrome virus","volume":"32","author":"Fang","year":"2006","journal-title":"Virus Genes"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0245","doi-asserted-by":"crossref","first-page":"9941","DOI":"10.1128\/JVI.07067-11","article-title":"N-linked glycosylation of GP5 of porcine reproductive and respiratory syndrome virus is critically important for virus replication in vivo","volume":"86","author":"Wei","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0250","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0255","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1016\/j.vaccine.2009.04.022","article-title":"Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology","volume":"27","author":"Kimman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0260","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.3390\/v6062392","article-title":"Alphavirus-based vaccines","volume":"6","author":"Lundstrom","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0265","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics \u2014 developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0270","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/tbed.13555","article-title":"A recombination between two type 1 porcine reproductive and respiratory syndrome virus (PRRSV-1) vaccine strains has caused severe outbreaks in Danish pigs","volume":"67","author":"Kvisgaard","year":"2020","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0275","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/JVI.01341-12","article-title":"Complete genome sequence of a novel variant porcine reproductive and respiratory syndrome virus (PRRSV) strain: evidence for recombination between vaccine and wild-type PRRSV strains","volume":"86","author":"Wenhui","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0280","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.3201\/eid2512.191111","article-title":"Recombination between vaccine and field strains of porcine reproductive and respiratory syndrome virus","volume":"25","author":"Wang","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jconrel.2021.09.008_bb0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5501\/wjv.v1.i1.23","article-title":"Porcine reproductive and respiratory syndrome virus vaccines: immunogenicity, efficacy and safety aspects","volume":"1","author":"Charerntantanakul","year":"2012","journal-title":"World J Virol"},{"key":"10.1016\/j.jconrel.2021.09.008_bb0290","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921004879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921004879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:16:42Z","timestamp":1759162602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921004879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":58,"alternative-id":["S0168365921004879"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.09.008","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyplex nanomicelle delivery of self-amplifying RNA vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}